00069-0249 Ruxience - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00069-0249

Brand Name:

Ruxience

Generic Name:

Rituximab-pvvr

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: RITUXIMAB

Strength: 500.0

Unit: mg/50mL

Packages:

Code: 00069-0249-01

Description: 1 VIAL, SINGLE-USE in 1 CARTON (0069-0249-01) / 50 mL in 1 VIAL, SINGLE-USE

Effective Date: Jan. 23, 2020

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CD20

Orphan Drug Designation:

Status:

In Use